2p7r

From Proteopedia

Cyclic pentapeptide which inhibits Hantavirus

Overview

Hantavirus-induced diseases such as hantavirus cardiopulmonary syndrome, and hemorrhagic fever with renal syndrome are a global health concern., Hantavirus cardiopulmonary syndrome caused by Sin Nombre virus lacks, specific therapy and its high mortality makes Sin Nombre virus a potential, bioweapon agent. Sin Nombre virus entry into susceptible cells requires, expression of alpha(v)beta(3) integrin. We recently reported the sequence, of a cyclic nonapeptide that inhibited Sin Nombre virus entry into Vero E6, cells at a level comparable to ReoPro, a Fab fragment of the anti-beta(3), antibody c7E3. Here, we refine the parental peptide, cyclo-[CPFVKTQLC], using alanine scanning and amino acid deletions, by optimizing for viral, inhibition. The IC(50) of the resulting peptide, cyclo-[CPFVC], was 267, microM compared with 263 microM for the parental peptide. The solution, structure of cyclo-[CPFVC] was determined by two-dimensional nuclear, magnetic resonance spectroscopy, revealing the Phe ring in an extended, conformation stacked against the Pro ring and containing a beta-turn, encompassing Val-4 through Cys-1. As an initial step in identifying, interactions between cyclo-[CPFVC] and its target cellular receptor, the, refined peptide structure was docked into the ReoPro binding site of, integrin beta(3). This structure will provide the basis for designing more, potent peptidomimetic therapeutics to prevent Sin Nombre virus entry and, treat hantavirus cardiopulmonary syndrome.

About this Structure

2P7R is a Protein complex structure of sequences from [1]. Full crystallographic information is available from OCA.

Reference

Characterization and NMR solution structure of a novel cyclic pentapeptide inhibitor of pathogenic hantaviruses., Hall PR, Malone L, Sillerud LO, Ye C, Hjelle BL, Larson RS, Chem Biol Drug Des. 2007 Mar;69(3):180-90. PMID:17441904

Page seeded by OCA on Wed Jan 23 11:06:54 2008